Adherium gets US sales approval

Australasian smart asthma inhaler device maker Adherium (ASX: ADR) has received US Food and Drug Administration clearance for over the counter sales of its Hailie sensors. The company, founded in New Zealand, listed in Australia and headquartered in the United States, manufactures connected respiratory devices. Its’ Hailie sensor attaches to a patient’s asthma inhaler, monitoring…